Related Experiment Video
Updated: Oct 25, 2026

Production of Monoclonal Antibodies Targeting Aminopeptidase N in the Porcine Intestinal Mucosal Epithelium
Published on: May 18, 2021
Oligopeptide-binding protein A is a potential target for combating Salmonella infection
Ken Yoshii1,2, Koichiro Suzuki1,3,4, Jun Adachi5
1Laboratory of Vaccine Materials and Laboratory of Gut Environmental System, Microbial Research Center for Health and Medicine, National Institutes of Biomedical Innovation, Health and Nutrition (NIBN), Osaka, Japan.
Introduction:
Salmonella infection remains a pervasive diarrheal illness, particularly affecting populations in developing countries. The lack of an effective vaccine against non-typhoidal Salmonella is attributable to antigenic diversity among serotypes, incomplete understanding of protective immune mechanisms, and the difficulty in identifying conserved antigens capable of eliciting broad cross-protective immunity.
Methods:
To identify conserved Salmonella antigens, we established a Salmonella-specific monoclonal antibody library using heat-killed bacteria. Candidate antigens recognized by monoclonal antibodies were characterized, and their functional relevance was evaluated through analyses of bacterial growth, respiratory activity, and protective effects in a murine Salmonella infection model.
Results:
We identified L2-1H11, a monoclonal antibody that recognizes OppA, a conserved antigen present across multiple Salmonella serotypes. L2-1H11 was associated with suppression of bacterial growth and respiratory activity and attenuated enteritis pathology in Salmonella-infected mice.
Conclusion:
These findings identify OppA as a conserved Salmonella antigen and suggest that it may represent a promising target for the development of subcutaneous and oral vaccines against Salmonella.
Related Concept Videos
Inhibitors of Bacterial Protein Synthesis
Factors Affecting Protein-Drug Binding: Protein-Related Factors
The physicochemical properties of a drug play a significant role in its ability to bind to proteins. Lipophilic drugs, which dissolve in fats, oils, and lipids, can be bound by...
Antimicrobial Proteins
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Factors Affecting Protein-Drug Binding: Drug-Related Factors
One crucial factor in drug-protein binding is the drug's lipophilicity or its affinity for fat. More lipophilic drugs tend to have higher binding extents. For example, highly lipophilic drugs like cloxacillin exhibit substantial protein binding, with as much as 95% of the drug binding to proteins. In contrast,...
Bacterial Translocation and Protein Secretion
Factors Affecting Protein-Drug Binding: Drug Interactions
Displacement interactions can have varying outcomes, ranging from toxicity to virtually...

